(Q40537255)

21 September 2017

title

Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells (English)

1 reference

21 September 2017

main subject

Orthoebolavirus zairense

0 references

0 references

Jane McHowat

5

0 references

Ratna B Ray

1

object named as

Ratna B Ray

1 reference

21 September 2017

Arnab Basu

2

1 reference

21 September 2017

Robert Steele

3

1 reference

21 September 2017

Aster Beyene

4

1 reference

21 September 2017

Keith Meyer

6

1 reference

21 September 2017

Asish K Ghosh

7

1 reference

21 September 2017

Ranjit Ray

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

21 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

21 September 2017

volume

321

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

181-188

1 reference

Inflammatory responses in Ebola virus-infected patients.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Molecular mechanisms of "detachment-induced apoptosis--Anoikis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Covalent modifications of the ebola virus glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Sensing the environment: a historical perspective on integrin signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Pro-apoptotic activity of transiently expressed BCL-2 occurs independent of BAX and BAK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Development of a preventive vaccine for Ebola virus infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Ebola virus pathogenesis: implications for vaccines and therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

The pathogenesis of Ebola hemorrhagic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Epitopes involved in antibody-mediated protection from Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.12.014

10.1016/J.VIROL.2003.12.014

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference